Tempus to Present at TD Cowen's 45th Annual Health Care Conference
Tempus AI (NASDAQ: TEM) has announced its participation in the TD Cowen 45th Annual Health Care Conference, scheduled for March 3-5, 2025, in Boston, MA. The company's Chief Financial Officer, Jim Rogers, will engage in a fireside discussion on Monday, March 3. The event will be accessible to viewers through a live webcast.
Tempus, which specializes in leveraging artificial intelligence for precision medicine and patient care advancement, will use this platform to share insights about their technology and healthcare initiatives.
Tempus AI (NASDAQ: TEM) ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen, prevista dal 3 al 5 marzo 2025 a Boston, MA. Il Direttore Finanziario dell'azienda, Jim Rogers, parteciperà a una discussione informale lunedì 3 marzo. L'evento sarà accessibile agli spettatori tramite una diretta web.
Tempus, specializzata nell'utilizzo dell'intelligenza artificiale per la medicina di precisione e il miglioramento dell'assistenza ai pazienti, utilizzerà questa piattaforma per condividere approfondimenti sulla propria tecnologia e le iniziative sanitarie.
Tempus AI (NASDAQ: TEM) ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen, programada del 3 al 5 de marzo de 2025 en Boston, MA. El Director Financiero de la compañía, Jim Rogers, participará en una discusión informal el lunes 3 de marzo. El evento será accesible para los espectadores a través de una transmisión en vivo.
Tempus, que se especializa en aprovechar la inteligencia artificial para la medicina de precisión y el avance en la atención al paciente, utilizará esta plataforma para compartir ideas sobre su tecnología e iniciativas de salud.
템퍼스 AI (NASDAQ: TEM)는 2025년 3월 3일부터 5일까지 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 의료 회의에 참여한다고 발표했습니다. 회사의 최고 재무 책임자인 짐 로저스가 3일 월요일에 포럼에서 대화에 참여할 예정입니다. 이 행사는 생중계로 시청자에게 제공됩니다.
정밀 의학 및 환자 치료 발전을 위한 인공지능 활용을 전문으로 하는 템퍼스는 이 플랫폼을 통해 자사의 기술 및 의료 이니셔티브에 대한 통찰력을 공유할 것입니다.
Tempus AI (NASDAQ: TEM) a annoncé sa participation à la 45ème Conférence Annuelle de Santé de TD Cowen, prévue du 3 au 5 mars 2025 à Boston, MA. Le Directeur Financier de l'entreprise, Jim Rogers, participera à une discussion informelle le lundi 3 mars. L'événement sera accessible aux spectateurs via un webcast en direct.
Tempus, qui se spécialise dans l'utilisation de l'intelligence artificielle pour la médecine de précision et l'avancement des soins aux patients, utilisera cette plateforme pour partager des informations sur sa technologie et ses initiatives en matière de santé.
Tempus AI (NASDAQ: TEM) hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen angekündigt, die vom 3. bis 5. März 2025 in Boston, MA, stattfinden wird. Der Finanzvorstand des Unternehmens, Jim Rogers, wird am Montag, den 3. März, an einer informellen Diskussion teilnehmen. Die Veranstaltung wird den Zuschauern über einen Live-Stream zugänglich gemacht.
Tempus, das sich darauf spezialisiert hat, Künstliche Intelligenz für präzisionsmedizinische und patientenorientierte Fortschritte zu nutzen, wird diese Plattform nutzen, um Einblicke in seine Technologie und Gesundheitsinitiativen zu teilen.
- None.
- None.
Tempus’ Chief Financial Officer, Jim Rogers, will participate in a fireside discussion at the conference on Monday, March 3. A live webcast of the conversation will be available here.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus’ industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding Tempus’ and its employee’s potential future speaking engagements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “going to,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release.
You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus’ business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus’ financial performance; the ability to attract and retain customers and partners; managing Tempus’ growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus’ intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled “Risk Factors” in Tempus’ Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the Securities and Exchange Commission (“SEC”) as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219140476/en/
Erin Carron
media@tempus.com
Source: Tempus AI, Inc.
FAQ
When is Tempus (TEM) presenting at the TD Cowen Healthcare Conference 2025?
Who will represent Tempus (TEM) at the 2025 TD Cowen Healthcare Conference?
How can investors watch Tempus' (TEM) presentation at the TD Cowen Conference?
What is the focus of Tempus' (TEM) business presentation at the healthcare conference?
